Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

Long-Term Evaluation of BIIB067

A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer

A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

BPS-314d-MR-PAH-303 (BEAT OLE)

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)

Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS)